Results 181 to 190 of about 197,147 (332)

Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y1 and Y2 receptors

British Journal of Pharmacology, 2011
I. Tough, Sarah Forbes, R. Tolhurst, Melina Ellis, Herbert Herzog, J. Bornstein, Helen M. Cox   +6 more
semanticscholar   +1 more source

Precision nutrition in weight loss and neuroendocrine control of people with obesity: The study protocol of a factorial randomised controlled trial (GenON Programme)

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Precision nutrition, guided by genetic testing, has emerged as a promising approach for managing obesity. However, robust clinical trials testing its effectiveness in real‐world dietary interventions remain scarce. The GenOn Programme aims to evaluate whether tailoring nutritional care based on genetic risk for obesity enhances weight ...
Karla P. Balbino, Ana Claudia P. Kravchychyn, Flávia G. Cândido, Mariana de Moura e Dias, Tiago Antônio de O. Mendes, Leandro Licursi de Oliveira, Luiza Carla V. Castro, Josefina Bressan, Ana Laura de la Garza, Fermín I. Milagro, María A. Zulet, Helen Hermana M. Hermsdorff   +11 more
wiley   +1 more source

Correction to "Identification of a G Protein-Coupled Receptor for Buccalin-Type Peptides in the Mollusk <i>Aplysia</i>: Evolutionary Insights into Neuropeptide Signaling". [PDF]

ACS Omega
Xu JP, Ding XY, Jin QC, Zhang YL, Chang JH, Jiang HM, Li YD, Fu P, Zhang YC, Liu CP, Mao RT, Liu CY, Li F, Wu SQ, Cropper EC, Zhang G, Jing J.   +16 more
europepmc   +1 more source

Current views on neuropeptide Y and diabetes-related atherosclerosis

Diabetes & vascular disease research, 2017
Weiwei Sun, Ping Zhu, Yanchuan Shi, Chen-liang Zhang, Xu-Feng Huang, Shi-yu Liang, Zhi-Yuan Song, Shu Lin   +7 more
semanticscholar   +1 more source

Diabetic kidney disease, biomarkers, and finerenone

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Diabetic kidney disease (DKD), the leading cause of kidney failure worldwide, is associated with an increased risk of cardiovascular disease (CVD). A complex pathobiology involving hemodynamic, metabolic, and immune dysregulation promotes inflammatory and fibrotic pathways that contribute to kidney disease progression and CVD in individuals ...
Ashish Verma, Ashish Upadhyay
wiley   +1 more source

Intracerebroventricular knockdown of NPY1R disrupts NPY1R-GALR2/TrkB heteroreceptor complexes without affecting neuroplasticity or depressive-like behaviour. [PDF]

J Psychopharmacol
Moreno-Madrid I, Arrabal-Gómez C, Romero-Imbroda J, Díaz-Casares A, Fuxe K, Borroto-Escuela D, Serrano-Castro P, Narváez M.   +7 more
europepmc   +1 more source

Gonadulin and Insulin‐Like Growth Factor Involved in Rhipicephalus microplus Reproduction

Entomologia Experimentalis et Applicata, EarlyView.
Insulin‐like growth factor (IGF2) in ovaries of Rhipicephalus microplus partially engorged females. Ovaries from females at different feeding stages were used to detect IGF2. ABSTRACT Gonadulin and insulin‐like growth factor (IGF) are neuropeptides synthesized by the central nervous system (CNS) of arthropods.
Jéssica Waldman, Lucas Teixeira de Castro, Vinícius Andrade‐Silva, Jéssica Andrade Paes, Luís Fernando Parizi, Maria Aparecida Juliano, Saulo Petinatti Pavarini, David Driemeier, Itabajara da Silva Vaz Jr.   +8 more
wiley   +1 more source

Thyroid Response to Peripheral Endocrine Factors: Neuropeptide Y Influences Thyroid Function in the Reptile <i>Podarcis siculus</i>. [PDF]

Int J Mol Sci
Sciarrillo R, Lallo A, Carrella F, Gallicchio V, Mileo A, Valvano BS, De Falco M.   +6 more
europepmc   +1 more source

Neuropeptide Y Receptor Type 5 [PDF]

, 2020
openaire   +1 more source

Nanoparticle‐encapsulated neuropeptide Y provides robust seizure protection in SCN1A‐derived epilepsy

Epilepsia, EarlyView.
Abstract Objective Neuropeptides have garnered great interest as potential treatments for epilepsy due to their impact on neuronal excitability through modulation of ion channels and neurotransmitter receptor activity. Neuropeptide Y (NPY) is a 36‐amino acid neuropeptide that is expressed primarily by γ‐aminobutyric acidergic (GABAergic) interneurons ...
Samantha L. Reed, Lauren M. Aiani, Eesha Faiz, Emmanuel Adediran, Morris Benveniste, Kevin S. Murnane, Martin D'Souza, Andrew Escayg, Jennifer C. Wong   +8 more
wiley   +1 more source